GLP-1 RAs were identified in the DRUG files using generic or brand names, including exenatide (BYETTA, BYDUREON BCISE), liraglutide (VICTOZA, SAXENDA, XULTOPHY), lixisenatide (LYXUMIA, ADLYXIN, SOLIQUA), dulaglutide (TRULICITY), semaglutide (OZEMPIC, RYBELSUS, WEGOVY), and tirzepatide (MOUNJARO, ZEPBOUND)
Source: Polaris Market Research Analysis To Understand More About this Research: Download Sample Report Acetyl-Glutathione Market Trends Rising Demand for Anti-Aging Supplements As individuals become more conscious of maintaining a youthful appearance and overall vitality, the demand for effective antioxidant solutions, such as acetyl-glutathione, is rising
High homocysteine can increase the risk of heart disease, so keeping it under control supports better circulation and a healthier cardiovascular system overall
Cobalamin deficiency
By reducing insulin levels, Naltrexone may indirectly enhance growth hormone levels, supporting weight loss and improving metabolism